Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson’s disease models
The potential of PEV-based therapies in neuroprotection opens new therapeutic avenues for neurodegenerative disorders. The study advocates for clinical trials to establish the efficacy of PEV-based biotherapies in neuroregenerative medicine.
Authors
- Thierry Pierre Robert Burnouf (ORCID: https://orcid.org/0000-0002-0507-9243)
- Liling Delila (ORCID: https://orcid.org/0000-0003-4979-3489)
- Szu‐Yi Chou (ORCID: https://orcid.org/0000-0002-4387-749X)
- Deng-Yao Lee
- Ming‐Li Chou (ORCID: https://orcid.org/0000-0002-6996-5332)
- Luc Buée (ORCID: https://orcid.org/0000-0002-6261-4230)
- David L Blum (ORCID: https://orcid.org/0000-0001-5691-431X)
- David Devos (ORCID: https://orcid.org/0000-0002-2417-799X)
- Kelly Timmerman
- Nhi Thao Ngoc Le (ORCID: https://orcid.org/0000-0002-9540-8564)
- Yu‐Wen Wu
- Ouada Nebie (ORCID: https://orcid.org/0000-0002-6802-4215)
Institutions
- National Yang Ming Chiao Tung University (TW)
- Inserm (FR)
- Université de Lille (FR)
- Institute of Biomedical Sciences, Academia Sinica (TW)
- Labex Corail (FR)
- Biomedical Translation Research Center (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Journal of Biomedical Science
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1186/s12929-024-01072-z
- Citations
- 30
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 7.01